Renal Cell Carcinoma News and Research

RSS
Renal cell carcinoma (RCC, also known as hypernephroma) is a kidney cancer that originates in the lining of the proximal convoluted tubule, the very small tubes in the kidney that filter the blood and remove waste products.
Heavier and taller children have high risk of developing renal cell carcinoma as adults

Heavier and taller children have high risk of developing renal cell carcinoma as adults

GARP protein can be a potential target for immunotherapy against colorectal cancer

GARP protein can be a potential target for immunotherapy against colorectal cancer

Overweight, obesity in adolescence associated with increased risk of renal cancer later in life

Overweight, obesity in adolescence associated with increased risk of renal cancer later in life

Drug combinations could become first-line treatment for metastatic kidney cancer

Drug combinations could become first-line treatment for metastatic kidney cancer

Scientists propose quick and pain-free method for diagnosing kidney cancer

Scientists propose quick and pain-free method for diagnosing kidney cancer

Obesity can be risk factor for developing renal cell carcinoma, confirms study

Obesity can be risk factor for developing renal cell carcinoma, confirms study

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Check your medical records for dangerous errors

Check your medical records for dangerous errors

Study identifies potential therapeutic strategy for patients with clear cell renal cancer

Study identifies potential therapeutic strategy for patients with clear cell renal cancer

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

X4 Pharmaceuticals announces clinical data of X4P-001-IO and Opdivo in patients with clear cell renal cell carcinoma

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets